Concepedia

Tyler Bonnett

TB

5

Publications

9.7K

Citations

5

H-Index

2020

Active since

Affiliations

Frederick National Laboratory for Cancer Research(Current)

The University of Texas Health Science Center at San Antonio

National Institute of Allergy and Infectious Diseases

Baylor College of Medicine

University of California, San Francisco

Tyler Bonnett is an author at Frederick National Laboratory for Cancer Research specializing in clinical trials, pharmacotherapy, and medicine.

ORCID

Top concepts

Publications per year

2020–2022

5

Publications

5

Remdesivir for the Treatment of Covid-19 — Final Report

John H. Beigel, Kay M Tomashek, Lori E. Dodd et al. · New England Journal of Medicine · 2020 · 7.6K citations · Full text

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

André C. Kalil, Thomas F. Patterson, Aneesh K. Mehta et al. · New England Journal of Medicine · 2020 · 1.9K citations · Full text

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial

Cameron R. Wolfe, Kay M Tomashek, Thomas F. Patterson et al. · The Lancet Respiratory Medicine · 2022 · 127 citations · Full text

, , +6

Deconstructing the Treatment Effect of Remdesivir in the Adaptive Coronavirus Disease 2019 (COVID-19) Treatment Trial-1: Implications for Critical Care Resource Utilization

Jonathan Fintzi, Tyler Bonnett, Daniel A. Sweeney et al. · Clinical Infectious Diseases · 2021 · 16 citations · Full text

Estimating associations between antidepressant use and incident mild cognitive impairment in older adults with depression

Fang Han, Tyler Bonnett, Willa D. Brenowitz et al. · PLoS ONE · 2020 · 14 citations · Full text

Rows per page

1–5 of 5